A.I.O.

This Week In Medicine

Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered! Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you. Each episode offers a filtered and concentrated summary of key journal articles, allowing you to stay informed without the need to sift through pages of research papers. W...

No dejes de visitar la web del podcast y apoyar a su creador: redcircle.com

Autor

A.I.O.

Categoría

Health

Web del podcast

redcircle.com

Último episodio

29 de oct. de 2026

¿Dónde escuchar?

Podcasts en la app Replaio Radio Muy pronto

Los podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts

Descárgala en Google Play Instálala gratis Android casi 10 M de descargas · valoración de 4,8 iOS muy pronto

Episodios

JAMA October 2026 Risk-Based vs Annual Breast Cancer Screening The WISDOM Randomized Clinical Trial 29.10.2026

A large-scale clinical trial involving more than 28,000 women was conducted to evaluate whether risk-based breast cancer screening serves as a viable substitute for traditional annual mammography. By utilizing genetic testing, polygenic risk scores, and clinical models, participants in the experimental group were assigned customized screening schedules tailored to their specific vulnerability leve...

JAMA October 2026 Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer The HORIZON-Breast06 Randomized Clinical Trial 29.10.2026

The HORIZON-Breast06 clinical trial investigated the effectiveness of trastuzumab rezetecan compared to standard chemotherapy for individuals suffering from ERBB2-low advanced breast cancer. Conducted across numerous medical centers in China, the multi-center study randomly divided 551 eligible participants into two distinct treatment groups. The primary focus of the research was to measure progre...

NEJM Oct 22 2026 Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis 28.10.2026

A recent international clinical trial investigated whether shortening antibiotic regimens for left-sided infective endocarditis is safe and effective once patients achieve clinical stability. Researchers compared a response-tailored strategy—which stopped antibiotics earlier—against the standard six-week duration across more than 500 participants. The findings revealed that the tailored approachsu...

NEJM Oct 22 2026 Ianalumab for the Treatment of Patients with Sjögren’s Disease 28.10.2026

Two clinical studies, NEPTUNUS-1 and NEPTUNUS-2, evaluated the effectiveness of the antibody ianalumab as a potential medical intervention for Sjögren's disease, a complicated autoimmune condition lacking specialized treatments. Researchers divided hundreds of participants into groups to compare monthly or quarterly subcutaneous injections of the medication against a placebo over the course of...

NEJM Oct 22 2026 Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event 28.10.2026

A recent clinical trial investigated whether the medication milvexian could safely lower the chances of secondary heart attacks and strokes in individuals recovering from acute coronary syndrome. Researchers administered either milvexian or a placebo alongside standard antiplatelet treatments to over fourteen thousand participants in this global study. Ultimately, the investigation was halted earl...

JAMA October 2026 Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans 13.10.2026

A recent retrospective study examined out-of-pocket expenses for working-age adults managing common chronic conditions like diabetes and hypertension. Researchers analyzed national commercial insurance claims from 2022 to 2023 to compare financial burdens between high-deductible health plans and traditional coverage. The findings revealed that patients enrolled in high-deductible policiesfaced ann...

JAMA October 2026 Patient Navigation Plus mHealth Incentives for Linkage to OUD Care for Adults Who Also Use Methamphetamines A Pilot Randomized Clinical Trial 13.10.2026

This clinical trial investigated a mobile health strategy combined with patient navigation to improve outpatient care for hospitalized adults struggling with both opioid use disorder and methamphetamine use. Researchers randomly assigned participants to receive either standard treatment or an intervention featuring financial rewards for medication adherence and dedicated support during the first m...

JAMA October 2026 Digital and Coaching Interventions for Uptake of Cancer Genetic Testing The MiGHT Randomized Clinical Trial 13.10.2026

The Michigan Genetic Hereditary Testing trial explored how to increase low completion rates for hereditary cancer genetic testing. Researchers evaluated nearly eight hundred adult participants who qualified for genetic evaluation across three different groups. Individuals were randomly assigned to receive either telephone-based health coaching, a self-directed digital tool, or standard care. The f...

JAMA Cardiology October 2026 Global, Regional, and National Burden of Heart Failure, 1990-2023 A Systematic Analysis for the Global Burden of Disease Study 2023 12.10.2026

A recent cross-sectional analysis utilizing Global Burden of Disease methodologies evaluates the worldwide impact and underlying causes of heart failure across 204 countries and territories from 1990 to 2023. By synthesizing extensive data, the research revealed an estimated 56.0 million cases globally in 2023, with prevalence rates consistently rising alongside advancing age. The study highlights...

JAMA Cardiology October 2026 Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease 12.10.2026

 recent systematic review and meta-analysis investigated how aggressively reducing blood pressure impacts heart health and renal function in adults. By examining twenty-seven randomized trials encompassing nearly ninety thousand participants, researchers compared intensive and standard blood pressure management strategies. The findings revealed that aggressive blood pressure reduction significantl...

JAMA October 2026 Development and Validation of an Adult Medical Urgency Score for US Donor Heart Allocation 12.10.2026

A recent observational study utilized registry data from adult heart transplant candidates to create and validate the US Candidate Risk Score (US-CRS) as a replacement for the current six-status allocation framework. This new quantitative model relies on specific laboratory values and mechanical support devices to more accurately assess a patient's risk of mortality while waiting for an organ....

JAMA October 2026 Advance Care Planning for Black and White Older Adults With Serious Illness The EQUAL ACP Randomized Trial 09.10.2026

The EQUAL ACP randomized trial investigated whether facilitated advance care planning outperforms self-guided methods for seriously ill older adults. Researchers evaluated completion rates over one year among nearly eight hundred Black and White participants aged sixty-five and older across multiple Southern clinics. Overall results indicated no statistically significant difference in completion b...

JAMA October 2026 Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease The NOPARK Randomized Clinical Trial 09.10.2026

A recent phase 3 clinical trial investigated whether the supplement nicotinamide riboside could slow the progression of early-stage Parkinson disease. Researchers across eleven centers in Norway administered either the substance or a placebo to 393 participants over a 52-week period. To measure disease severity, the study tracked changes using standard movement and non-motor symptom scales. Ultima...

NEJM 10 8 2026 Vasopressors or Fluids in Early Septic Shock 09.10.2026

Vasopressors or Fluids in Early Septic Shock

NEJM 10 8 2026 Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis 09.10.2026

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

NEJM 10 8 2026 Tricuspid-Valve Intervention in Heart Failure 09.10.2026

Researchers conducted a clinical trial to determine whether transcatheter tricuspid-valve repair could improve health outcomes for older adults suffering from severe tricuspid regurgitation and heart failure risks. Participants were randomly divided to receive either the combined procedure with medical treatment or standard medication alone. At the one-year mark, the evaluation showed significantl...

NEJM 10 1 2026 Giredestrant plus Everolimus in Advanced Breast Cancer 07.10.2026

Giredestrant plus Everolimus in Advanced Breast Cancer

NEJM 10 1 2026 Obexelimab for the Treatment of IgG4-Related Disease 07.10.2026

A recent phase 3 clinical trial investigated obexelimab, a novel monoclonal antibody that suppresses B-cell function without destroying the cells, as a potential therapy for IgG4-related disease. Standard treatments typically rely on glucocorticoids, which often cause significant toxicity and frequently lead to relapses once stopped. To test the medication, 194 patients were randomly assigned to r...

NEJM 10 1 2026 Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults 07.10.2026

Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults

JAMA 9 2026Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement A Randomized Clinical Trial 24.09.2026

This clinical study investigates whether applying a local anesthetic directly into the uterus can alleviate the discomfort typically associated with IUD insertion for women who have never given birth. By comparing the effects of mepivacaine against a saltwater placebo, researchers discovered that the medication significantly lowered pain scores and improved the overall tolerability of the procedur...

JAMA 9 2026 Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act 24.09.2026

This retrospective study evaluates whether the expansion of Medicare Advantage eligibility for patients with end-stage kidney disease has impacted their ability to receive life-saving treatments. By comparing data from 2021 through 2023, researchers discovered that those enrolled in private Medicare Advantage plans faced significantly lower rates of kidney transplantation and new wait-listing comp...

JAMA 9 2026 Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion The ATTENTION LATE Randomized Clinical Trial 24.09.2026

This clinical study investigated whether administering the clot-busting drug tenecteplase prior to a surgical thrombectomy would benefit patients experiencing a severe stroke in the back of the brain. Researchers focused specifically on individuals who arrived at the hospital in a late time window, between 4.5 and 24 hours after their symptoms began. The trial discovered that adding the medication...

NEJM 9 17 2026 Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy 21.09.2026

This clinical study investigated whether a mother’s diet during pregnancy and breastfeeding could influence the development of food sensitivities in children with a high genetic risk for allergies. Researchers compared a group of women who consumed large quantities of eggs and peanuts to a control group following a standard diet to see if early allergen exposure via the womb or breast milk offered...

NEJM 9 17 2026 Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock 21.09.2026

This clinical study investigated whether administering sodium bicarbonate could improve outcomes for intensive care patients suffering from metabolic acidosis and circulatory shock. Researchers conducted a randomized trial to determine if correcting blood acidity would reduce major adverse kidney events or lower the risk of death for those already requiring blood pressure support. The results demo...

NEJM 9 17 2026 Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal 21.09.2026

This study investigates whether extending the time between follow-up screenings for patients who have had high-risk polyps removed compromises their long-term health. By comparing a five-year surveillance interval against the standard three-year recommendation, researchers sought to determine if less frequent monitoring is just as effective at preventing the development of colorectal cancer. The i...

Escucha el podcast This Week In Medicine en Replaio

Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno

Descárgala en Google Play

Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos